Skip to main content

Latest SEC Filings — Page 175

Page 175 · 30 filings scored 7+ · newest 4:20 PM ET · How scores work

Thu, Aug 1330 filings
7KLCKinderCare Learning Companies, Inc.KinderCare Q2 Misses, Guides FY26 Adjusted EPS to $0.05-$0.15Form 8-K · Current report▼ Negative9PDSBPDS Biotechnology CorpPDS Biotech 10-Q: $5.6M Cash, Going Concern Doubt, Nasdaq Delisting RiskForm 10-Q · Periodic report▼ NegativePro7OXBROXBRIDGE RE HOLDINGS LtdOxbridge Re Swings to Q2 Profit, Launches AI Data Center UnitForm 8-K · Current report▲ Positive7ADIGADI Global Distribution Inc.ADI Global Distribution's First Standalone 10-Q Details Q2 Results and Post-Spin-Off FinancingForm 10-Q · Periodic report● Neutral7MIDDMIDDLEBY CorpMiddleby Q2 2026 10-Q: Strong Commercial Foodservice Growth, $566M Buyback, and Spin-off DetailsForm 10-Q · Periodic report▲ Positive8TPCSTechPrecision CorpTechPrecision Q1 Revenue Jumps 23% but Going Concern Doubt PersistsForm 10-Q · Periodic report▼ NegativePro7ALMSALUMIS INC.Alumis Q2 Loss Widens on $41.8M Impairment; Cash Runway Extends to 2027Form 10-Q · Periodic report● Neutral7FOSLFossil Group, Inc.Fossil Group Q2 10-Q: Gross Margin Hits 62.4%, Turnaround Progress ContinuesForm 10-Q · Periodic report● Neutral8RDZNRoadzen Inc.Roadzen Posts Record Q1 FY2027 Revenue of $16.2M, Up 49% YoY; Adjusted EBITDA Loss Narrows to $(0.37)MForm 8-K · Current report▲ PositivePro8QNTQuantinuum Inc.Quantinuum's First 10-Q Details $2.1B Cash, $447M Stock Comp, and $112M Warrant Mark-to-Market LossForm 10-Q · Periodic report▼ NegativePro8DFDVDeFi Development Corp.DeFi Development Corp. Reports $27.3M Q2 Loss, Material Weaknesses, and ATM SalesForm 10-Q · Periodic report▼ NegativePro9FFAIFaraday Future Intelligent Electric Inc.Faraday Future Flags Going Concern Doubt, $81.3M Loss, and Material WeaknessesForm 10-Q · Periodic report▼ NegativePro8FTHMFathom Holdings Inc.Fathom's Q2 Loss Widens to $6.2M; Material Weaknesses Remediated, Nasdaq Compliance RegainedForm 10-Q · Periodic report▼ NegativePro7ELTPElite Pharmaceuticals, Inc.Elite Pharmaceuticals Q1 FY2027 Revenue Falls 19.5% to $32.4M; Net Income $5.9MForm 8-K · Current report▼ Negative7XOSXos, Inc.Xos Reports Q2 Revenue Drop to $4.7M, Cuts Full-Year OutlookForm 8-K · Current report▼ Negative8MBRXMoleculin Biotech, Inc.Moleculin 10-Q: Going Concern, Nasdaq Delisting Risk, and Director ResignationForm 10-Q · Periodic report▼ NegativePro7NCNANuCana plcNuCana Q2 Loss Narrows to £3.1M; Cash Runway Extended into 2029Form 6-K · Current report▲ Positive8KODKodiak Sciences Inc.Kodiak Sciences Q2 2026: $65.6M Net Loss, Going Concern Warning, Cash Runway into 2027Form 10-Q · Periodic report▼ NegativePro9BZAIBlaize Holdings, Inc.Blaize Q2 Revenue Jumps to $12M but Gross Margin Collapses to 8%; FY26 Guidance Cut to $40-43MForm 8-K · Current report▼ NegativePro7PETSPetMed Express, Inc.PetMed Q1 Loss Narrows to $6.1M, Sales Stabilize SequentiallyForm 8-K · Current report▼ Negative7OXBROXBRIDGE RE HOLDINGS LtdOxbridge Re Swings to Q2 Profit on Tokenized Reinsurance FeesForm 10-Q · Periodic report▲ Positive7WATTEnergous CorpEnergous Q2 2026 10-Q: Revenue Up 217%, Cash at $31.2M, ATM Proceeds $31.8MForm 10-Q · Periodic report▲ Positive8RANIRani Therapeutics Holdings, Inc.Nasdaq Delisting Deadline and Unremediated Material Weakness Weigh on Rani TherapeuticsForm 10-Q · Periodic report▼ NegativePro8ETONEton Pharmaceuticals, Inc.Eton Pharmaceuticals Q2 2026: Revenue Nearly Doubles, Profitability SoarsForm 10-Q · Periodic report▲ PositivePro8BCHTBirchtech Corp.Birchtech Q2 2026: Going Concern Alleviated, But Material Weaknesses PersistForm 10-Q · Periodic report▼ NegativePro8VERIVeritone, Inc.Veritone Q2 Revenue Rises 4.6% to $24.3M, Guides FY26 Revenue to $100M-$115MForm 8-K · Current report● NeutralPro7KANPKAANAPALI LAND LLCKaanapali Land Q2 Loss Widens, But Cash Surges to $38M After Land SaleForm 10-Q · Periodic report● Neutral8FFAIFaraday Future Intelligent Electric Inc.Faraday Future Q2 Revenue Jumps 1,400% to $836K, Net Loss Narrows 69%, Regains Nasdaq ComplianceForm 8-K · Current report▲ PositivePro8AXTIAXT INCAXT Q2 2026 10-Q: $47.6M Revenue, $11.1M Net Income, and $87M Lumentum Capacity DealForm 10-Q · Periodic report▲ PositivePro7AIIAmerican Integrity Insurance Group, Inc.American Integrity Q2 10-Q Confirms Record Earnings, Details Reinsurance Program and Financial Statement RevisionForm 10-Q · Periodic report▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.